4 Results for "

SNX2112

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "SNX2112" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-10214
CAS No.: 908112-43-6
Purity:  99.49%
Synonyms: PF-04928473
Target:  

HSP Autophagy

Research Areas:  

Cancer

SNX-2112 (PF 04928473) is an orally active Hsp90 inhibitor, with a Kd of 16 nM for Hsp90 and IC50s of 30 nM, 30 nM for Hsp90 α and Hsp90 β, also induces Her-2 degradation, and inhibits Grp94 and Trap-1, with IC50s of 10 nM, 4.275 μM and 0.862 μM, respectively . SNX-2112 (PF 04928473) binds Hsp90 isoforms Hsp90α, Hsp90β and Hsp90b1/Grp94 with Kds of 4 nM, 6 nM and 484 nM, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-10213
CAS No.: 908115-27-5
Purity:  99.11%
Synonyms: PF-04929113
Research Areas:  

Cancer

SNX-5422 (PF-04929113), a prodrug of SNX-2112, is an orally active Hsp90 inhibitor, with a Kd of 41 nM, and also induces Her-2 degradation, with an IC50 of 37 nM.
loading...
    loading...
Cat. No.: HY-10214R
CAS No.: 908112-43-6
Synonyms: PF-04928473 (Standard)
Research Areas:  

Cancer

SNX-2112 (Standard) is the analytical standard of SNX-2112 (HY-10214). This product is intended for research and analytical applications. SNX-2112 (PF 04928473) is an orally active Hsp90 inhibitor, with a Kd of 16 nM for Hsp90 and IC50s of 30 nM, 30 nM for Hsp90 α and Hsp90 β, also induces Her-2 degradation, and inhibits Grp94 and Trap-1, with IC50s of 10 nM, 4.275 μM and 0.862 μM, respectively . SNX-2112 (PF 04928473) binds Hsp90 isoforms Hsp90α, Hsp90β and Hsp90b1/Grp94 with Kds of 4 nM, 6 nM and 484 nM, respectively .
loading...
    loading...
Cat. No.: HY-10213A
CAS No.: 1173111-67-5
Synonyms: PF-04929113 mesylate
Research Areas:  

Cancer

SNX-5422 Mesylate (PF-04929113 Mesylate), a prodrug of SNX-2112, is an orally active Hsp90 inhibitor, with a Kd of 41 nM, and also induces Her-2 degradation, with an IC50 of 37 nM.
loading...
    loading...